FI941388L - Paineistetut aerosolikoostumukset - Google Patents

Paineistetut aerosolikoostumukset Download PDF

Info

Publication number: FI941388L
Authority: FI; Finland
Prior art keywords: pressurized aerosol; aerosol compositions; compositions; pressurized; aerosol
Prior art date: 1991-09-25

Application number

FI941388A

Other languages

English (en)

Swedish (sv)

Other versions

FI110407B (fi

FI941388A0 (fi

Inventor

Suresh Nagarbhai Mistry

Mark Gibson

Original Assignee

Fisons Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-09-25

Filing date

1994-03-25

Publication date

1994-03-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27450754&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI941388(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-09-25 Priority claimed from GB919120396A external-priority patent/GB9120396D0/en

1991-09-28 Priority claimed from GB919120675A external-priority patent/GB9120675D0/en

1991-11-19 Priority claimed from GB919124661A external-priority patent/GB9124661D0/en

1992-02-14 Priority claimed from GB929203212A external-priority patent/GB9203212D0/en

1994-03-25 Application filed by Fisons Plc filed Critical Fisons Plc

1994-03-25 Publication of FI941388A0 publication Critical patent/FI941388A0/fi

1994-03-25 Publication of FI941388L publication Critical patent/FI941388L/fi

2003-01-31 Application granted granted Critical

2003-01-31 Publication of FI110407B publication Critical patent/FI110407B/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Otolaryngology (AREA)
General Health & Medical Sciences (AREA)
Pulmonology (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Colloid Chemistry (AREA)

FI941388A 1991-09-25 1994-03-25 Menetelmä paineistetun aerosolikoostumuksen valmistamiseksi FI110407B (fi)

Applications Claiming Priority (10)

Application Number	Priority Date	Filing Date	Title
GB919120396A GB9120396D0 (en)	1991-09-25	1991-09-25	Formulations
GB9120396		1991-09-25
GB919120675A GB9120675D0 (en)	1991-09-28	1991-09-28	Formulation
GB9120675		1991-09-28
GB9124661		1991-11-19
GB919124661A GB9124661D0 (en)	1991-11-19	1991-11-19	Formulations
GB9201749		1992-01-28
GB9203212		1992-02-14
GB929203212A GB9203212D0 (en)	1992-02-14	1992-02-14	Pharmaceutical formulations
PCT/GB1992/001749 WO1993005765A1 (en)	1991-09-25	1992-09-23	Pressurised aerosol compositions

Publications (3)

Publication Number	Publication Date
FI941388A0 FI941388A0 (fi)	1994-03-25
FI941388L true FI941388L (fi)	1994-03-25
FI110407B FI110407B (fi)	2003-01-31

Family

ID=27450754

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI941388A FI110407B (fi)	1991-09-25	1994-03-25	Menetelmä paineistetun aerosolikoostumuksen valmistamiseksi

Country Status (28)

Country	Link
US (1)	US6641800B1 (fi)
EP (2)	EP0605578B2 (fi)
JP (1)	JP3142136B2 (fi)
KR (1)	KR100275426B1 (fi)
CN (1)	CN1050285C (fi)
AT (1)	ATE132739T1 (fi)
AU (1)	AU654397B2 (fi)
BG (1)	BG61752B1 (fi)
BR (1)	BR9206549A (fi)
CA (1)	CA2119932C (fi)
CZ (1)	CZ282506B6 (fi)
DE (1)	DE69207606T3 (fi)
DK (1)	DK0605578T4 (fi)
ES (1)	ES2082507T5 (fi)
FI (1)	FI110407B (fi)
GR (2)	GR3019098T3 (fi)
HU (2)	HUT67480A (fi)
IL (1)	IL103238A (fi)
MX (1)	MX9205483A (fi)
MY (1)	MY108309A (fi)
NO (1)	NO307124B1 (fi)
NZ (1)	NZ244439A (fi)
RO (1)	RO114735B1 (fi)
RU (1)	RU2122852C1 (fi)
SK (1)	SK279456B6 (fi)
TW (1)	TW216442B (fi)
UA (1)	UA41873C2 (fi)
WO (1)	WO1993005765A1 (fi)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7105152B1 (en)	1991-12-18	2006-09-12	3M Innovative Properties Company	Suspension aerosol formulations
US7101534B1 (en)	1991-12-18	2006-09-05	3M Innovative Properties Company	Suspension aerosol formulations
GB9214819D0 (en) *	1992-07-13	1992-08-26	Minnesota Mining & Mfg	Valve assemblies
JPH08507792A (ja) *	1993-03-17	1996-08-20	ミネソタマイニングアンドマニュファクチャリングカンパニー	ジオール−二酸から誘導される分散助剤を含むエーロゾル配合物
JP3987963B2 (ja) *	1993-03-17	2007-10-10	スリーエムカンパニー	エステルー，アミド−又はメルカプトエステル−誘導分散促進剤を含むエーロゾル配合物
JP3875993B2 (ja)	1995-06-27	2007-01-31	ベーリンガーインゲルハイムコマンディトゲゼルシャフト	噴射剤を含まないエアゾールを製造するための新規で安定な医薬調製物
GB9616237D0 (en)	1996-08-01	1996-09-11	Norton Healthcare Ltd	Aerosol formulations
US6039932A (en) *	1996-09-27	2000-03-21	3M Innovative Properties Company	Medicinal inhalation aerosol formulations containing budesonide
US6126919A (en)	1997-02-07	2000-10-03	3M Innovative Properties Company	Biocompatible compounds for pharmaceutical drug delivery systems
US20010031244A1 (en)	1997-06-13	2001-10-18	Chiesi Farmaceutici S.P.A.	Pharmaceutical aerosol composition
US6946117B1 (en)	1997-09-29	2005-09-20	Nektar Therapeutics	Stabilized preparations for use in nebulizers
US6309623B1 (en)	1997-09-29	2001-10-30	Inhale Therapeutic Systems, Inc.	Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en)	1997-09-29	2006-07-27	Nektar Therapeutics	Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en)	1997-09-29	2003-05-20	Inhale Therapeutic Systems, Inc.	Methods of spray drying pharmaceutical compositions
US6433040B1 (en)	1997-09-29	2002-08-13	Inhale Therapeutic Systems, Inc.	Stabilized bioactive preparations and methods of use
US6086376A (en) *	1998-01-30	2000-07-11	Rtp Pharma Inc.	Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6451285B2 (en) *	1998-06-19	2002-09-17	Baker Norton Pharmaceuticals, Inc.	Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6136294C1 (en) *	1998-09-22	2002-09-24	Aeropharm Technology Inc	Amino acid stabilized medical aerosol formulation
DZ2947A1 (fr)	1998-11-25	2004-03-15	Chiesi Farma Spa	Inhalateur à compteur de dose sous pression.
IT1313553B1 (it)	1999-07-23	2002-09-09	Chiesi Farma Spa	Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US6540982B1 (en) *	2000-01-25	2003-04-01	Aeropharm Technology Incorporated	Medical aerosol formulation
IT1317846B1 (it)	2000-02-22	2003-07-15	Chiesi Farma Spa	Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
EP1274433A1 (en) *	2000-04-13	2003-01-15	Innovata Biomed Limited	Medicaments for treating respiratory disorders comprising formoterol and fluticasone
EP1280520B2 (en)	2000-05-10	2018-03-21	Novartis AG	Phospholipid-based powders for drug delivery
US7871598B1 (en)	2000-05-10	2011-01-18	Novartis Ag	Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en)	2000-05-10	2013-03-26	Novartis Ag	Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
ME00220B (me)	2000-05-22	2010-10-10	Chiesi Farm Spa	Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
SI1273292T1 (en)	2001-07-02	2004-12-31	Chiesi Farmaceutici S.P.A.	Optimised formulation of tobramycin for aerosolization
GB0208742D0 (en)	2002-04-17	2002-05-29	Bradford Particle Design Ltd	Particulate materials
ATE508735T1 (de)	2001-12-19	2011-05-15	Novartis Ag	Pulmonale verabreichung von aminoglykosiden
US7544177B2 (en) *	2002-01-24	2009-06-09	The Regents Of The University Of California	Aerosol device to deliver bioactive agent
SE0200312D0 (sv) *	2002-02-01	2002-02-01	Astrazeneca Ab	Novel composition
US7582284B2 (en)	2002-04-17	2009-09-01	Nektar Therapeutics	Particulate materials
US7244742B2 (en) *	2002-08-17	2007-07-17	Boehringer Ingelheim Pharma Gmbh & Co Kg	Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
GB0328630D0 (en) *	2003-12-10	2004-01-14	Medpharm Ltd	Metered dose inhalation preparations
EP1595531A1 (en)	2004-05-13	2005-11-16	CHIESI FARMACEUTICI S.p.A.	Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EP1732527A2 (en) *	2004-03-17	2006-12-20	Mpex Pharmaceuticals, Inc.	Use and administration of bacterial efflux pump inhibitors
US7994225B2 (en) *	2004-03-17	2011-08-09	Rempex Pharmaceuticals, Inc.	Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
US20070031343A1 (en) *	2005-08-04	2007-02-08	Bonfour Charles A Iii	Flavored medicinal inhalant
FR2895260B1 (fr) *	2005-12-23	2009-02-20	Servier Lab	Nouvelle composition pharmaceutique a base d'huile essentielle pour pulverisation nasale et/ou buccale
DE102006017320A1 (de) *	2006-04-11	2007-10-18	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
PT2425820E (pt)	2007-02-11	2015-08-04	Map Pharmaceuticals Inc	Método de administração terapêutica de dhe para permitir o rápido alívio das enxaquecas ao mesmo tempo que minimiza o perfil de efeitos secundários
WO2008152398A2 (en) *	2007-06-14	2008-12-18	Cipla Limited	Formulations for inhalation
GB0712454D0 (en)	2007-06-27	2007-08-08	Generics Uk Ltd	Pharmaceutical compositions
WO2009137438A2 (en)	2008-05-06	2009-11-12	Wilson-Cook Medical Inc.	Apparatus and methods for delivering therapeutic agents
WO2010052466A2 (en) *	2008-11-04	2010-05-14	Cipla Limited	Pharmaceutical aerosol composition
US8361054B2 (en)	2008-12-23	2013-01-29	Cook Medical Technologies Llc	Apparatus and methods for containing and delivering therapeutic agents
US8118777B2 (en)	2009-05-29	2012-02-21	Cook Medical Technologies Llc	Systems and methods for delivering therapeutic agents
US9101744B2 (en)	2009-05-29	2015-08-11	Cook Medical Technologies Llc	Systems and methods for delivering therapeutic agents
CN102416179B (zh)	2010-09-28	2014-05-07	益得生物科技股份有限公司	用于哮喘的吸入性复方组合物
US9867931B2 (en)	2013-10-02	2018-01-16	Cook Medical Technologies Llc	Therapeutic agents for delivery using a catheter and pressure source
US11931227B2 (en)	2013-03-15	2024-03-19	Cook Medical Technologies Llc	Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
GB201402513D0 (en) *	2014-02-13	2014-04-02	Cardiff Scintigraphics Ltd	Pressurised metered dose inhalers and method of manufacture
EP3174522A1 (en)	2014-07-29	2017-06-07	3M Innovative Properties Company	Method of preparing a pharmaceutical composition
MX381589B (es) *	2015-10-23	2025-03-12	Basf Se	Formulaciones con liberación controlada de perfumes para aplicación dérmica.
US10702495B2 (en)	2017-02-20	2020-07-07	Nexien Biopharma, Inc.	Method and compositions for treating dystrophies and myotonia
EP3750528A1 (en)	2019-06-11	2020-12-16	Nexien Biopharma, Inc.	Compositions for treating dystrophies and myotonia
CN115697176A (zh)	2020-06-05	2023-02-03	库克医学技术有限责任公司	用于递送治疗剂的医疗窥镜
WO2023287654A1 (en)	2021-07-14	2023-01-19	Cook Medical Technologies, LLC	Systems and methods for preventing clogging of a delivery system
US12496429B2 (en)	2022-10-18	2025-12-16	Cook Medical Technologies Llc	Systems and methods for delivering pressurized fluid to a target site alone or in conjunction with therapeutic agents

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US417295A (en) *		1889-12-17		Fabriken
AT274245B (de)	1967-05-17	1969-09-10		Verfahren zur Herstellung eines Spezialklebers für Verbandmaterialien
US4025635A (en)	1972-09-06	1977-05-24	Burroughs Wellcome Co.	Cyclic sulphur compounds
CA1136547A (en) *	1979-03-08	1982-11-30	Song-Ling Lin	Aerosol anesthetic compositions
EP0175671A1 (de)	1984-08-23	1986-03-26	Kuhlemann & Co.	Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
AU601176B2 (en)	1986-03-10	1990-09-06	Kurt Burghart	Benzodiazepine aerosols
US4869899A (en) *	1986-03-10	1989-09-26	Walter Burghart	Pharmaceutical preparation and process for producing the same
US4752466A (en)	1987-08-31	1988-06-21	Johnson & Johnson Products, Inc.	Thrombin aerosol
US5225183A (en)	1988-12-06	1993-07-06	Riker Laboratories, Inc.	Medicinal aerosol formulations
GB8828477D0 (en) *	1988-12-06	1989-01-05	Riker Laboratories Inc	Medical aerosol formulations
GB8921222D0 (en)	1989-09-20	1989-11-08	Riker Laboratories Inc	Medicinal aerosol formulations
IL95952A0 (en)	1989-10-19	1991-07-18	Sterling Drug Inc	Aerosol composition for topical medicament
IE67185B1 (en)	1990-02-02	1996-03-06	Fisons Plc	Propellant compositions
US6123924A (en) *	1991-09-25	2000-09-26	Fisons Plc	Pressurized aerosol inhalation compositions
US5658549A (en)	1991-12-12	1997-08-19	Glaxo Group Limited	Aerosol formulations containing propellant 134a and fluticasone propionate
US5874064A (en) *	1996-05-24	1999-02-23	Massachusetts Institute Of Technology	Aerodynamically light particles for pulmonary drug delivery

1992
- 1992-09-22 IL IL10323892A patent/IL103238A/en not_active IP Right Cessation
- 1992-09-22 NZ NZ244439A patent/NZ244439A/en not_active IP Right Cessation
- 1992-09-23 ES ES92920611T patent/ES2082507T5/es not_active Expired - Lifetime
- 1992-09-23 CA CA002119932A patent/CA2119932C/en not_active Expired - Lifetime
- 1992-09-23 UA UA94005331A patent/UA41873C2/uk unknown
- 1992-09-23 KR KR1019940700969A patent/KR100275426B1/ko not_active Expired - Lifetime
- 1992-09-23 EP EP92920611A patent/EP0605578B2/en not_active Expired - Lifetime
- 1992-09-23 AU AU26471/92A patent/AU654397B2/en not_active Expired
- 1992-09-23 WO PCT/GB1992/001749 patent/WO1993005765A1/en not_active Ceased
- 1992-09-23 EP EP92308657A patent/EP0534731A1/en active Pending
- 1992-09-23 AT AT92920611T patent/ATE132739T1/de active
- 1992-09-23 CZ CZ94695A patent/CZ282506B6/cs not_active IP Right Cessation
- 1992-09-23 HU HU9400853A patent/HUT67480A/hu unknown
- 1992-09-23 RO RO94-00492A patent/RO114735B1/ro unknown
- 1992-09-23 MY MYPI92001697A patent/MY108309A/en unknown
- 1992-09-23 JP JP05505930A patent/JP3142136B2/ja not_active Expired - Fee Related
- 1992-09-23 RU RU94022269/14A patent/RU2122852C1/ru active
- 1992-09-23 DK DK92920611T patent/DK0605578T4/da active
- 1992-09-23 SK SK340-94A patent/SK279456B6/sk not_active IP Right Cessation
- 1992-09-23 DE DE69207606T patent/DE69207606T3/de not_active Expired - Lifetime
- 1992-09-23 BR BR9206549A patent/BR9206549A/pt not_active Application Discontinuation
- 1992-09-25 MX MX9205483A patent/MX9205483A/es unknown
- 1992-09-25 CN CN92112491A patent/CN1050285C/zh not_active Expired - Lifetime
- 1992-09-29 TW TW081107686A patent/TW216442B/zh not_active IP Right Cessation
1994
- 1994-03-24 BG BG98681A patent/BG61752B1/bg unknown
- 1994-03-24 NO NO941077A patent/NO307124B1/no not_active IP Right Cessation
- 1994-03-25 FI FI941388A patent/FI110407B/fi not_active IP Right Cessation
1995
- 1995-03-20 HU HU95P/P00090P patent/HU210818A9/hu unknown
1996
- 1996-02-23 GR GR960400518T patent/GR3019098T3/el unknown
1999
- 1999-12-10 GR GR990403193T patent/GR3032103T3/el unknown
2000
- 2000-07-13 US US09/616,069 patent/US6641800B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2082507T5 (es)	1999-11-16
IL103238A0 (en)	1993-02-21
HUT67480A (en)	1995-04-28
EP0605578B1 (en)	1996-01-10
US6641800B1 (en)	2003-11-04
ATE132739T1 (de)	1996-01-15
NO941077D0 (no)	1994-03-24
ES2082507T3 (es)	1996-03-16
HK1005564A1 (en)	1999-01-15
SK34094A3 (en)	1994-11-09
FI110407B (fi)	2003-01-31
RO114735B1 (ro)	1999-07-30
NZ244439A (en)	1994-01-26
TW216442B (en)	1993-11-21
DE69207606T3 (de)	2000-03-16
GR3032103T3 (en)	2000-03-31
DK0605578T4 (da)	2000-03-06
CZ282506B6 (cs)	1997-07-16
IL103238A (en)	1995-07-31
EP0605578A1 (en)	1994-07-13
CN1071832A (zh)	1993-05-12
BG61752B1 (bg)	1998-05-29
FI941388A0 (fi)	1994-03-25
CN1050285C (zh)	2000-03-15
AU654397B2 (en)	1994-11-03
EP0605578B2 (en)	1999-09-22
EP0534731A1 (en)	1993-03-31
GR3019098T3 (en)	1996-05-31
CA2119932A1 (en)	1993-04-01
SK279456B6 (sk)	1998-11-04
DE69207606T2 (de)	1996-06-27
DK0605578T3 (da)	1996-03-25
JPH07502262A (ja)	1995-03-09
CA2119932C (en)	2002-05-21
AU2647192A (en)	1993-04-27
BG98681A (bg)	1995-02-28
MY108309A (en)	1996-09-30
JP3142136B2 (ja)	2001-03-07
KR100275426B1 (ko)	2001-03-02
HU9400853D0 (en)	1994-06-28
RU2122852C1 (ru)	1998-12-10
DE69207606D1 (de)	1996-02-22
WO1993005765A1 (en)	1993-04-01
UA41873C2 (uk)	2001-10-15
HU210818A9 (en)	1995-08-28
CZ69594A3 (en)	1995-11-15
BR9206549A (pt)	1995-10-17
MX9205483A (es)	1993-05-01
NO941077L (no)	1994-05-18
NO307124B1 (no)	2000-02-14

Publication	Publication Date	Title
FI941388L (fi)	1994-03-25	Paineistetut aerosolikoostumukset
FI925852A7 (fi)	1992-12-23	Paineistetut aerosolikoostumukset
ATE201587T1 (de)	2001-06-15	Aerosolzusammensetzungen
NO920987D0 (no)	1992-03-13	Farmasoeytiske aerosolformuleringer
FI945524A7 (fi)	1995-05-28	Aerosolilääkekoostumuksia
FI935464A7 (fi)	1993-12-07	Kloorifluorihiilettömät aerosoliformulaatiot
FI935463A7 (fi)	1993-12-07	Kloorifluorihiilettömät aerosoliformulaatiot
DE69424181D1 (de)	2000-05-31	Flunisolide aerosolformulierungen
DE69232419D1 (de)	2002-03-21	Strahlungshärtbare cyclobutaren zusammensetzungen
PT100649A (pt)	1994-05-31	Valvula de aerossol
FI910237A7 (fi)	1991-07-18	Atropiini-salbutamoliaerosoli
EE9400195A (et)	1996-02-15	Aerosoolpihusti
NO934230D0 (no)	1993-11-23	Vaskemiddelblandinger
DK0599461T3 (da)	1997-03-24	Hærdelige sammensætninger
NZ240518A (en)	1993-01-27	Aerosol compositions
ZA914897B (en)	1992-03-25	Pressurised aerosol compositions
PH30964A (en)	1997-12-23	Pressurised aerosol compositions.
NO950391D0 (no)	1995-02-02	Vaskemiddelblandinger
GB9114915D0 (en)	1991-08-28	Pressurised aerosol formulation
DE3991103T1 (de)	1990-11-22	Mechanisch druckbeaufschlagter aerosol-spender
GB9114277D0 (en)	1991-08-21	Aerosol formulation
GB9002037D0 (en)	1990-03-28	Pharmaceutical aerosol compositions

Legal Events

Date	Code	Title	Description
2012-11-01	MA	Patent expired